Research / LYB / Fundamental state Inspectable configuration
State dimensions Filing 0001489393-22-000009 General Corporate
Capex intensity 22th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.34% · OPTIONAL · VALID
Operating cash generation 72th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.05% · OPTIONAL · VALID
Revenue growth 86th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
67.20% · CORE · VALID
Inventory pressure 0th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
10.86% · OPTIONAL · VALID
Operating margin 61th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
15.01% · CORE · VALID
R&D intensity 6th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.27% · OPTIONAL · VALID
SBC intensity 56th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.15% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 33 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 4.14%
Current 4.34%
Delta 0.20% Cash Generation Decreased
Previous 17.28%
Current 17.05%
Delta -0.23% Growth Decreased
Previous 88.26%
Current 67.20%
Delta -21.07% Inventory Pressure Decreased
Previous 40.17%
Current 10.86%
Delta -29.32% Profitability Decreased
Previous 18.13%
Current 15.01%
Delta -3.12% R And D Intensity Increased
Previous 0.24%
Current 0.27%
Delta 0.03% Sbc Intensity Increased
Previous 0.12%
Current 0.15%
Delta 0.03% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.